BRIGHAM AND WOMEN'S HOSPITAL
Control of Pulmonary Inflammation by Leukotriene E4
Control of Pulmonary Inflammation by Leukotriene E4 is a funding opportunity from BRIGHAM AND WOMEN'S HOSPITAL, up to 700679, closing July 31, 2026.
Jul 31, 2026
(0d left)Overview
Abstract/Summary This application for continuing support focuses on the mechanisms by which the cysteinyl leukotrienes (cysLTs), a class of potent lipid inflammatory mediators, facilitate type 2 (eosinophilic) immunopathology (T2I) that underlies prevalent and burdensome respiratory diseases, including asthma and…